Title : The MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study.

Pub. Date : 2022 Feb 22

PMID : 34933330






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study. RG7388 MDM2 proto-oncogene Homo sapiens
2 Idasanutlin, an MDM2 antagonist, showed clinical activity and rapid reduction in JAK2 V617F allele burden in patients with polycythemia vera (PV) in a phase 1 study. RG7388 MDM2 proto-oncogene Homo sapiens